Valuation: OraSure Technologies, Inc.

Market Cap 29Cr 26Cr 24Cr 22Cr 41Cr 2.82TCr 42Cr 282.09Cr 110.81Cr 1.38TCr 109.89Cr 107.47Cr 4.75TCr P/E 2026 *
-4.05x
P/E 2027 * -5.18x
Enterprise Value 29Cr 26Cr 24Cr 22Cr 41Cr 2.82TCr 42Cr 282.09Cr 110.81Cr 1.38TCr 109.89Cr 107.47Cr 4.75TCr EV / Sales 2026 *
2.44x
EV / Sales 2027 * 2.29x
Free-Float
93.62%
Yield 2026 *
-
Yield 2027 * -
1 day-5.06%
1 week-5.48%
Current month-9.19%
1 month-6.25%
3 months+26.17%
6 months+50.56%
Current year+67.36%
1 week 4.05
Extreme 4.05
4.36
1 month 4.05
Extreme 4.05
4.58
Current year 2.33
Extreme 2.33
4.58
1 year 2.08
Extreme 2.08
4.58
3 years 2.08
Extreme 2.08
8.45
5 years 2.08
Extreme 2.08
13.57
10 years 2.08
Extreme 2.08
23.01
Manager TitleAgeSince
Chief Executive Officer 52 04/06/2022
Director of Finance/CFO 54 08/08/2022
Chief Tech/Sci/R&D Officer - 01/12/2024
Director TitleAgeSince
Director/Board Member 59 01/06/2020
Director/Board Member 66 08/11/2021
Director/Board Member 52 04/06/2022
Date Insider Type Main position Quantity % Market Cap.
26/06/26 Free

Director

3,666 0.0053%
03/06/26 Free

Director

46,106 0.0670%
03/06/26 Free

Chairman

46,106 0.0670%
Change 5-day change 1-year change 3-year change Capi.($)
-4.82%-5.48%+26.96%-11.38% 29Cr
+11.49%+4.98%-24.78%-7.38% 16TCr
+3.62%+1.15%-7.17%-3.89% 10TCr
+3.29%+1.16%+2.73%+59.25% 5.77TCr
-1.11%+4.77%+38.09%+52.37% 5.23TCr
+2.44%+5.17%-11.01%-38.18% 4.27TCr
+2.76%-1.03% - - 3.34TCr
+6.39%+5.85%-8.12%-43.77% 2.81TCr
+1.03%+1.43%+61.67%-5.44% 2.54TCr
-0.85%+4.34%-3.58%-18.20% 2.1TCr
Average +2.36%+0.20%+8.31%-1.85% 5.19TCr
Weighted average by Cap. +5.06%-1.71%-3.38%+2.52%

Financials

2026 *2027 *
Net sales 12Cr 10Cr 9.68Cr 8.88Cr 17Cr 1.15TCr 17Cr 115.39Cr 45Cr 563.22Cr 45Cr 44Cr 1.94TCr 13Cr 11Cr 10Cr 9.48Cr 18Cr 1.23TCr 18Cr 123.25Cr 48Cr 601.58Cr 48Cr 47Cr 2.08TCr
Net income -7.37Cr -6.44Cr -5.96Cr -5.47Cr -10Cr -709.96Cr -11Cr -71Cr -28Cr -346.7Cr -28Cr -27Cr -1.2TCr -5.76Cr -5.04Cr -4.66Cr -4.28Cr -8.09Cr -555.47Cr -8.23Cr -56Cr -22Cr -271.25Cr -22Cr -21Cr -936.49Cr
Net Debt - -
Logo OraSure Technologies, Inc.
OraSure Technologies, Inc. transforms health through actionable insight and decentralizes diagnostics to connect people to healthcare wherever they are. The Company, together with its wholly owned subsidiaries, DNA Genotek Inc. and Sherlock Biosciences, Inc., is engaged in the development, manufacture, and distribution of rapid diagnostic tests and sample collection and stabilization devices designed to discover and detect critical medical conditions. Its products and services include OraQuick ADVANCE Rapid HIV 1/2 Antibody Test, OraQuick HIV Self-Test, Diagnostics Direct Syphilis Health Check, OraQuick Ebola Rapid Antigen Test, InteliSwab COVID-19 Rapid Test Pro, and SickleSCAN Test, among others. Its portfolio of products is sold globally to clinical laboratories, hospitals, physician’s offices, clinics, public health and community-based organizations, research institutions, government agencies, pharmaceutical companies, and direct consumers.
Employees
500
Date Price Change Volume
16/26/16 $4.065 -4.35% 1,66,683
15/26/15 $4.250 -0.23% 2,96,428
14/26/14 $4.260 -0.93% 3,77,037
13/26/13 $4.300 +0.12% 2,66,957
10/26/10 $4.295 +0.23% 2,34,501
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
4.250USD
Average target price
4.750USD
Spread / Average Target
+11.76%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. OSUR Stock